Pratam Fin Serv
Pratam Fin Serv is a venture capital firm based in Pune, India. This profile covers what we know about Pratam Fin Serv and how founders can get in front of it in 2026.
Pratam Fin Serv is a financial services company providing business loans, capital financing, and investment solutions.
- Location
- Pune, India
- Team size
- 51-100
How to pitch Pratam Fin Serv
The founders who hear back from Pratam Fin Serv lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Pratam Fin Serv
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Pratam Fin Serv." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/pratam-fin-serv
Frequently Asked Questions
What is Pratam Fin Serv?
Pratam Fin Serv is a venture capital firm based in Pune, India. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Pratam Fin Serv based?
Pratam Fin Serv is based in Pune, India. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Pratam Fin Serv?
Unlock a verified email for Pratam Fin Serv and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.